FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to dermatology, and can be used in the treatment of patients with rosacea. The method includes taking doxycycline 100 mg per day orally and applying azelaic acid - 15% gel - 2 times a day to all affected areas of the skin. As a drug, ethoxidol is additionally prescribed orally at 100 mg 3 times a day for a course of 30 days.
EFFECT: method provides a more pronounced therapeutic effect, long-term remission, does not cause side effects, allergic reactions, has a noticeable antioxidant effect and leads to the normalization of the clinical picture of the disease due to the additional intake of ethoxidol in the specified dosage.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATMENT OF PATIENTS WITH ROSACEA | 2022 |
|
RU2793793C1 |
METHOD OF ANTIOXIDANT STATUS CORRECTION IN TREATING ERYTHEMATOUS-TELANGIECTATIC AND PAPULOPUSTULAR FORMS OF ROSACEA OF MILD AND MODERATE SEVERITY | 2020 |
|
RU2741988C1 |
METHOD OF LOCAL TREATMENT OF FACIAL PAPULOPUSTULAR DERMATOSES | 2022 |
|
RU2790768C1 |
METHOD FOR COMBINATION THERAPY OF ROSACEA | 2021 |
|
RU2806053C2 |
METHOD OF COMPLEX EXTRINSIC FOR PATIENTS WITH ERITHEMATOUS PAPULAR ROSACEA | 2017 |
|
RU2645932C1 |
DEVICE AND METHOD FOR LOCAL TREATMENT OF PAPULO-PAPULOPUSTULAR SHAPE ROSACEA | 2014 |
|
RU2583559C2 |
METHOD OF COMBINED EXTERNAL THERAPY OF ERYTHEMATOUS-PAPULAR ROSACEA | 2019 |
|
RU2697854C1 |
METHOD FOR OUTPATIENT TREATMENT OF FACIAL SKIN OF PATIENTS WITH ROSACEA | 2015 |
|
RU2577297C1 |
METHOD OF TREATING ACNE | 2011 |
|
RU2455009C1 |
METHOD OF TREATING MODERATE ERYTHEMATOTELANGIECTATIC ROSACEA AGAINST BACKGROUND OF SENSITIZATION TO PYROGLYPHIDE MITES | 2022 |
|
RU2806514C1 |
Authors
Dates
2023-01-13—Published
2022-05-04—Filed